258 related articles for article (PubMed ID: 17904538)
1. Recombinant Sendai virus induces T cell immunity against respiratory syncytial virus that is protective in the absence of antibodies.
Voges B; Vallbracht S; Zimmer G; Bossow S; Neubert WJ; Richter K; Hobeika E; Herrler G; Ehl S
Cell Immunol; 2007 Jun; 247(2):85-94. PubMed ID: 17904538
[TBL] [Abstract][Full Text] [Related]
2. Intranasal immunization with a replication-deficient adenoviral vector expressing the fusion glycoprotein of respiratory syncytial virus elicits protective immunity in BALB/c mice.
Fu Y; He J; Zheng X; Wu Q; Zhang M; Wang X; Wang Y; Xie C; Tang Q; Wei W; Wang M; Song J; Qu J; Zhang Y; Wang X; Hong T
Biochem Biophys Res Commun; 2009 Apr; 381(4):528-32. PubMed ID: 19233131
[TBL] [Abstract][Full Text] [Related]
3. Single mucosal immunization of recombinant adenovirus-based vaccine expressing F1 protein fragment induces protective mucosal immunity against respiratory syncytial virus infection.
Kim S; Jang JE; Yu JR; Chang J
Vaccine; 2010 May; 28(22):3801-8. PubMed ID: 20362203
[TBL] [Abstract][Full Text] [Related]
4. Alphavirus replicon particles encoding the fusion or attachment glycoproteins of respiratory syncytial virus elicit protective immune responses in BALB/c mice and functional serum antibodies in rhesus macaques.
Elliott MB; Chen T; Terio NB; Chong SY; Abdullah R; Luckay A; Egan MA; Boutilier LA; Melville K; Lerch RA; Long D; Eldridge JH; Parks CL; Udem SA; Hancock GE
Vaccine; 2007 Oct; 25(41):7132-44. PubMed ID: 17850933
[TBL] [Abstract][Full Text] [Related]
5. Pulmonary T cells induced by respiratory syncytial virus are functional and can make an important contribution to long-lived protective immunity.
Ostler T; Ehl S
Eur J Immunol; 2002 Sep; 32(9):2562-9. PubMed ID: 12207340
[TBL] [Abstract][Full Text] [Related]
6. Plasmid DNA encoding the respiratory syncytial virus G protein is a promising vaccine candidate.
Li X; Sambhara S; Li CX; Ettorre L; Switzer I; Cates G; James O; Parrington M; Oomen R; Du RP; Klein M
Virology; 2000 Mar; 269(1):54-65. PubMed ID: 10725198
[TBL] [Abstract][Full Text] [Related]
7. Induction of balanced immunity in BALB/c mice by vaccination with a recombinant fusion protein containing a respiratory syncytial virus G protein fragment and a CTL epitope.
Zeng RH; Gong W; Fan CF; Wang YF; Mei XG
Vaccine; 2006 Feb; 24(7):941-7. PubMed ID: 16159685
[TBL] [Abstract][Full Text] [Related]
8. Influenza virus vaccine expressing fusion and attachment protein epitopes of respiratory syncytial virus induces protective antibodies in BALB/c mice.
Bian C; Liu S; Liu N; Zhang G; Xing L; Song Y; Duan Y; Gu H; Zhou Y; Zhang P; Li Z; Zhang K; Wang Z; Zhang S; Wang X; Yang P
Antiviral Res; 2014 Apr; 104():110-7. PubMed ID: 24509239
[TBL] [Abstract][Full Text] [Related]
9. Long-lasting balanced immunity and protective efficacy against respiratory syncytial virus in mice induced by a recombinant protein G1F/M2.
Zeng R; Qi X; Gong W; Mei X; Wei L; Ma C; Yin X
Vaccine; 2007 Oct; 25(42):7422-8. PubMed ID: 17850930
[TBL] [Abstract][Full Text] [Related]
10. A prime-boost vaccination strategy using attenuated Salmonella typhimurium and a replication-deficient recombinant adenovirus vector elicits protective immunity against human respiratory syncytial virus.
Fu YH; He JS; Wang XB; Zheng XX; Wu Q; Xie C; Zhang M; Wei W; Tang Q; Song JD; Qu JG; Hong T
Biochem Biophys Res Commun; 2010 Apr; 395(1):87-92. PubMed ID: 20350532
[TBL] [Abstract][Full Text] [Related]
11. [Plasmid construction, expression, immunogenicity and protective efficacy of recombinant protein candidate vaccine of respiratory syncytial virus].
Zeng RH; Gong W; Fang XP; Zhang ZY; Mei XG
Sheng Wu Gong Cheng Xue Bao; 2005 Jul; 21(4):534-9. PubMed ID: 16176088
[TBL] [Abstract][Full Text] [Related]
12. Fusion of DsbA to the N-terminus of CTL chimeric epitope, F/M2:81-95, of respiratory syncytial virus prolongs protein- and virus-specific CTL responses in Balb/c mice.
Fan CF; Zeng RH; Sun CY; Mei XG; Wang YF; Liu Y
Vaccine; 2005 Apr; 23(22):2869-75. PubMed ID: 15780735
[TBL] [Abstract][Full Text] [Related]
13. Sendai virus recombinant vaccine expressing a secreted, unconstrained respiratory syncytial virus fusion protein protects against RSV in cotton rats.
Zhan X; Slobod KS; Jones BG; Sealy RE; Takimoto T; Boyd K; Surman S; Russell CJ; Portner A; Hurwitz JL
Int Immunol; 2015 May; 27(5):229-36. PubMed ID: 25477211
[TBL] [Abstract][Full Text] [Related]
14. Protection against respiratory syncytial virus by a recombinant Newcastle disease virus vector.
Martinez-Sobrido L; Gitiban N; Fernandez-Sesma A; Cros J; Mertz SE; Jewell NA; Hammond S; Flano E; Durbin RK; García-Sastre A; Durbin JE
J Virol; 2006 Feb; 80(3):1130-9. PubMed ID: 16414990
[TBL] [Abstract][Full Text] [Related]
15. Respiratory syncytial virus (RSV) fusion protein expressed by recombinant Sendai virus elicits B-cell and T-cell responses in cotton rats and confers protection against RSV subtypes A and B.
Zhan X; Hurwitz JL; Krishnamurthy S; Takimoto T; Boyd K; Scroggs RA; Surman S; Portner A; Slobod KS
Vaccine; 2007 Dec; 25(52):8782-93. PubMed ID: 18037543
[TBL] [Abstract][Full Text] [Related]
16. Non-propagating, recombinant vesicular stomatitis virus vectors encoding respiratory syncytial virus proteins generate potent humoral and cellular immunity against RSV and are protective in mice.
Johnson JE; McNeil LK; Megati S; Witko SE; Roopchand VS; Obregon JH; Illenberger DM; Kotash CS; Nowak RM; Braunstein E; Yurgelonis I; Jansen KU; Kalyan NK; Sidhu MK
Immunol Lett; 2013 Feb; 150(1-2):134-44. PubMed ID: 23261719
[TBL] [Abstract][Full Text] [Related]
17. Contribution of respiratory syncytial virus G antigenicity to vaccine-enhanced illness and the implications for severe disease during primary respiratory syncytial virus infection.
Johnson TR; Graham BS
Pediatr Infect Dis J; 2004 Jan; 23(1 Suppl):S46-57. PubMed ID: 14730270
[TBL] [Abstract][Full Text] [Related]
18. Subcellular site of expression and route of vaccination influence pulmonary eosinophilia following respiratory syncytial virus challenge in BALB/c mice sensitized to the attachment G protein.
Bembridge GP; Garcia-Beato R; López JA; Melero JA; Taylor G
J Immunol; 1998 Sep; 161(5):2473-80. PubMed ID: 9725246
[TBL] [Abstract][Full Text] [Related]
19. Respiratory syncytial virus subunit vaccine based on a recombinant fusion protein expressed transiently in mammalian cells.
Nallet S; Amacker M; Westerfeld N; Baldi L; König I; Hacker DL; Zaborosch C; Zurbriggen R; Wurm FM
Vaccine; 2009 Oct; 27(46):6415-9. PubMed ID: 19559121
[TBL] [Abstract][Full Text] [Related]
20. Membrane-associated respiratory syncytial virus F protein expressed from a human rhinovirus type 14 vector is immunogenic.
Dollenmaier G; Mosier SM; Scholle F; Sharma N; McKnight KL; Lemon SM
Virology; 2001 Mar; 281(2):216-30. PubMed ID: 11277694
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
